Impact of CYLD on chromatin structure and histone methylation in malignant melanoma

The tumor suppressive role of CYLD lysine 63 deubiquitinase (CYLD) is known in melanoma. To the bestof our knowledge, however, the precise mechanism underlying the tumor suppressive function of CYLD has yet to be clarified. In the present study, a novel melanoma mouse model was generated, which reve...

Descripción completa

Detalles Bibliográficos
Autores: Schott, M. (Mandy)|||/items/f55b3a1c-567a-4dfd-bbb0-8a60d9063fcd, Kappelmann-Fenzl, M. (Melanie)|||/items/3e84ede2-5a27-4621-bc3f-5643eb3ab9eb, Fischer, S. (Stefan)|||/items/0192afc1-95d2-47e8-86e2-7d112879f26e, Fernández-Barrena, M.G. (Maite G.)|||/items/cfa77580-40b9-43a4-b237-b234ef7fb6cb, Pineda-Lucena, A. (Antonio)|||/items/aabeed59-b8b3-4787-a803-a5fc7136ef9f, Avila, M.A. (Matías Antonio)|||/items/3ad9abbb-c18d-445b-86cf-cb76be15419f, Kuphal, S. (Silke)|||/items/5e64691f-751b-401d-833e-eebb73c93913, Bosserhoff, A.K. (Anja-Katrin)|||/items/1470b7f0-f5e6-43b2-a326-1bf7ff91db87
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/118760
Acceso en línea:https://hdl.handle.net/10171/118760
Access Level:acceso abierto
Palabra clave:CYLD lysine 63 deubiquitinase
H3K9me2
Chromatin accessibility
Epigenetic
Euchromatic histone lysine methyltransferase 2
Melanoma
id ES_85329e3cd28303e6a007dfaa1b2ea2ef
oai_identifier_str oai:dadun.unav.edu:10171/118760
network_acronym_str ES
network_name_str España
repository_id_str
spelling Impact of CYLD on chromatin structure and histone methylation in malignant melanomaSchott, M. (Mandy)|||/items/f55b3a1c-567a-4dfd-bbb0-8a60d9063fcdKappelmann-Fenzl, M. (Melanie)|||/items/3e84ede2-5a27-4621-bc3f-5643eb3ab9ebFischer, S. (Stefan)|||/items/0192afc1-95d2-47e8-86e2-7d112879f26eFernández-Barrena, M.G. (Maite G.)|||/items/cfa77580-40b9-43a4-b237-b234ef7fb6cbPineda-Lucena, A. (Antonio)|||/items/aabeed59-b8b3-4787-a803-a5fc7136ef9fAvila, M.A. (Matías Antonio)|||/items/3ad9abbb-c18d-445b-86cf-cb76be15419fKuphal, S. (Silke)|||/items/5e64691f-751b-401d-833e-eebb73c93913Bosserhoff, A.K. (Anja-Katrin)|||/items/1470b7f0-f5e6-43b2-a326-1bf7ff91db87CYLD lysine 63 deubiquitinaseH3K9me2Chromatin accessibilityEpigeneticEuchromatic histone lysine methyltransferase 2MelanomaThe tumor suppressive role of CYLD lysine 63 deubiquitinase (CYLD) is known in melanoma. To the bestof our knowledge, however, the precise mechanism underlying the tumor suppressive function of CYLD has yet to be clarified. In the present study, a novel melanoma mouse model was generated, which revealed accelerated tumor growth in Cyld‑knockout (Cyld‑/‑) compared with Cyld‑wild‑type (Cyld+/+) mice. To determine the underlying molecular mechanism, mutation analysis of primary tumor‑derived cell lines from Cyld+/+ and Cyld‑/‑ mice was performed using RNA sequencing data. Variant calling revealed no common mutations in Cyld‑/‑ compared with Cyld+/+ cells. Thus, the epigenetic processes influencing development and progression of melanoma were investigated. Initial analysis of expression pattern of known hypermethylated genes in melanoma (suppressor of cytokine signalling, methylthioadenosine phosphorylase, cadherin 1) in the presence or absence of 5'‑Aza‑deoxyctidine treatment revealed that CYLD does not play a key role in DNA methylation. Chromatin accessibility and histone H3 modification assay uncovered a role of CYLD in the formation of chromatin structure. Subsequent inhibitor experiments confirmed the effect of CYLD on H3K9me2 level associated with heterochromatin. Furthermore, enhanced H3K9 dimethylation in Cyld‑/‑ melanoma cells was associated with upregulation of euchromatic histone lysine methyltransferase 2 (EHMT2). Moreover, the specific inhibitor of EHMT2, CM272, resulted in decreased proliferation and relaxation of compact chromatin in Cyld‑deficient melanoma cells. These results reveal a novel role of CYLD in histone methylation and chromatin packaging.D.A. SpandidosDadun. Depósito Académico Digital Universidad de Navarra20222022-01-0120222022-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/118760reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/1187602026-06-21T12:47:57Z
dc.title.none.fl_str_mv Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
title Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
spellingShingle Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
Schott, M. (Mandy)|||/items/f55b3a1c-567a-4dfd-bbb0-8a60d9063fcd
CYLD lysine 63 deubiquitinase
H3K9me2
Chromatin accessibility
Epigenetic
Euchromatic histone lysine methyltransferase 2
Melanoma
title_short Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
title_full Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
title_fullStr Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
title_full_unstemmed Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
title_sort Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
dc.creator.none.fl_str_mv Schott, M. (Mandy)|||/items/f55b3a1c-567a-4dfd-bbb0-8a60d9063fcd
Kappelmann-Fenzl, M. (Melanie)|||/items/3e84ede2-5a27-4621-bc3f-5643eb3ab9eb
Fischer, S. (Stefan)|||/items/0192afc1-95d2-47e8-86e2-7d112879f26e
Fernández-Barrena, M.G. (Maite G.)|||/items/cfa77580-40b9-43a4-b237-b234ef7fb6cb
Pineda-Lucena, A. (Antonio)|||/items/aabeed59-b8b3-4787-a803-a5fc7136ef9f
Avila, M.A. (Matías Antonio)|||/items/3ad9abbb-c18d-445b-86cf-cb76be15419f
Kuphal, S. (Silke)|||/items/5e64691f-751b-401d-833e-eebb73c93913
Bosserhoff, A.K. (Anja-Katrin)|||/items/1470b7f0-f5e6-43b2-a326-1bf7ff91db87
author Schott, M. (Mandy)|||/items/f55b3a1c-567a-4dfd-bbb0-8a60d9063fcd
author_facet Schott, M. (Mandy)|||/items/f55b3a1c-567a-4dfd-bbb0-8a60d9063fcd
Kappelmann-Fenzl, M. (Melanie)|||/items/3e84ede2-5a27-4621-bc3f-5643eb3ab9eb
Fischer, S. (Stefan)|||/items/0192afc1-95d2-47e8-86e2-7d112879f26e
Fernández-Barrena, M.G. (Maite G.)|||/items/cfa77580-40b9-43a4-b237-b234ef7fb6cb
Pineda-Lucena, A. (Antonio)|||/items/aabeed59-b8b3-4787-a803-a5fc7136ef9f
Avila, M.A. (Matías Antonio)|||/items/3ad9abbb-c18d-445b-86cf-cb76be15419f
Kuphal, S. (Silke)|||/items/5e64691f-751b-401d-833e-eebb73c93913
Bosserhoff, A.K. (Anja-Katrin)|||/items/1470b7f0-f5e6-43b2-a326-1bf7ff91db87
author_role author
author2 Kappelmann-Fenzl, M. (Melanie)|||/items/3e84ede2-5a27-4621-bc3f-5643eb3ab9eb
Fischer, S. (Stefan)|||/items/0192afc1-95d2-47e8-86e2-7d112879f26e
Fernández-Barrena, M.G. (Maite G.)|||/items/cfa77580-40b9-43a4-b237-b234ef7fb6cb
Pineda-Lucena, A. (Antonio)|||/items/aabeed59-b8b3-4787-a803-a5fc7136ef9f
Avila, M.A. (Matías Antonio)|||/items/3ad9abbb-c18d-445b-86cf-cb76be15419f
Kuphal, S. (Silke)|||/items/5e64691f-751b-401d-833e-eebb73c93913
Bosserhoff, A.K. (Anja-Katrin)|||/items/1470b7f0-f5e6-43b2-a326-1bf7ff91db87
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv CYLD lysine 63 deubiquitinase
H3K9me2
Chromatin accessibility
Epigenetic
Euchromatic histone lysine methyltransferase 2
Melanoma
topic CYLD lysine 63 deubiquitinase
H3K9me2
Chromatin accessibility
Epigenetic
Euchromatic histone lysine methyltransferase 2
Melanoma
description The tumor suppressive role of CYLD lysine 63 deubiquitinase (CYLD) is known in melanoma. To the bestof our knowledge, however, the precise mechanism underlying the tumor suppressive function of CYLD has yet to be clarified. In the present study, a novel melanoma mouse model was generated, which revealed accelerated tumor growth in Cyld‑knockout (Cyld‑/‑) compared with Cyld‑wild‑type (Cyld+/+) mice. To determine the underlying molecular mechanism, mutation analysis of primary tumor‑derived cell lines from Cyld+/+ and Cyld‑/‑ mice was performed using RNA sequencing data. Variant calling revealed no common mutations in Cyld‑/‑ compared with Cyld+/+ cells. Thus, the epigenetic processes influencing development and progression of melanoma were investigated. Initial analysis of expression pattern of known hypermethylated genes in melanoma (suppressor of cytokine signalling, methylthioadenosine phosphorylase, cadherin 1) in the presence or absence of 5'‑Aza‑deoxyctidine treatment revealed that CYLD does not play a key role in DNA methylation. Chromatin accessibility and histone H3 modification assay uncovered a role of CYLD in the formation of chromatin structure. Subsequent inhibitor experiments confirmed the effect of CYLD on H3K9me2 level associated with heterochromatin. Furthermore, enhanced H3K9 dimethylation in Cyld‑/‑ melanoma cells was associated with upregulation of euchromatic histone lysine methyltransferase 2 (EHMT2). Moreover, the specific inhibitor of EHMT2, CM272, resulted in decreased proliferation and relaxation of compact chromatin in Cyld‑deficient melanoma cells. These results reveal a novel role of CYLD in histone methylation and chromatin packaging.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/118760
url https://hdl.handle.net/10171/118760
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv D.A. Spandidos
publisher.none.fl_str_mv D.A. Spandidos
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869412280276353024
score 15.812455